Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia

NCT00440843 is registered in ClinicalTrials.gov with VA Connecticut Healthcare System as lead sponsor.

NCT NCT00440843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia
Lead sponsor
VA Connecticut Healthcare System
Phase
Phase 3
Overall status
Withdrawn
Start date
February 28, 2007
Completion date
June 30, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia